ArticleBioscience reports2022

Correction: Remodeling of the tumor microenvironment using an engineered oncolytic vaccinia virus improves PD-L1 inhibition outcomes.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.